摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[(3,4-二氟苯基)甲基]-3-(7-羟基萘-1-基)脲 | 648420-34-2

中文名称
1-[(3,4-二氟苯基)甲基]-3-(7-羟基萘-1-基)脲
中文别名
——
英文名称
1-(3,4-Difluoro-benzyl)-3-(7-hydroxy-naphthalen-1-yl)-urea
英文别名
1-(3,4-Difluorobenzyl)-3-(7-hydroxy-1-naphthyl)urea;1-[(3,4-difluorophenyl)methyl]-3-(7-hydroxynaphthalen-1-yl)urea
1-[(3,4-二氟苯基)甲基]-3-(7-羟基萘-1-基)脲化学式
CAS
648420-34-2
化学式
C18H14F2N2O2
mdl
——
分子量
328.318
InChiKey
VKVZYBVXAPIOHR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    514.0±50.0 °C(Predicted)
  • 密度:
    1.409±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    61.4
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为产物:
    参考文献:
    名称:
    7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1
    摘要:
    A series of structurally simple 7-hydroxynaphthalenyl ureas and amides were discovered to be potent ligands of human vanilloid receptor I (VR1). 1-(7-Hydroxynaphthaten-1-yl)-3-(4-trifluoromethylbenzyl)urea 5f exhibited nanomolar binding affinity (K-i = 1.0 nM) and upon capsaicin challenge, behaved as a potent functional antagonist (IC50 = 4 nM). The synthesis and structure-activity relationships (SARs) for the series are described. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.09.090
点击查看最新优质反应信息

文献信息

  • 7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1
    作者:Mark E. McDonnell、Sui-Po Zhang、Nadia Nasser、Adrienne E. Dubin、Scott L. Dax
    DOI:10.1016/j.bmcl.2003.09.090
    日期:2004.1
    A series of structurally simple 7-hydroxynaphthalenyl ureas and amides were discovered to be potent ligands of human vanilloid receptor I (VR1). 1-(7-Hydroxynaphthaten-1-yl)-3-(4-trifluoromethylbenzyl)urea 5f exhibited nanomolar binding affinity (K-i = 1.0 nM) and upon capsaicin challenge, behaved as a potent functional antagonist (IC50 = 4 nM). The synthesis and structure-activity relationships (SARs) for the series are described. (C) 2003 Elsevier Ltd. All rights reserved.
查看更多